| (210) | Number of the EPO application | 19710788 |
| (220) | Filing date of the EPO application | 2019.02.14 |
| (80) | EPO patent specification publication (B) | EPB nr. 23/2024, 2024.06.05 |
| (110) | EPO patent number | 3752141 |
| (11) | Number of the document | MD 3752141 T2 |
| (21) | Number of the application | e 2020 1273 |
| (71) | Name(s) of applicant(s), code of the country | INTRABIO LTD, GB, GB; |
| (72) | Name(s) of inventor(s), code of the country | FACTOR Mallory, GB;
STRUPP Michael, DE; |
| (73) | Name(s) of owner(s), code of the country | INTRABIO LTD, GB; |
| (54) | Title of the invention | Acetyl-leucine for use in treating restless leg syndrome |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 31/198 (2006.01.01); A61P 25/00 (2006.01.01) |
| (19) | Country | GB |
| (41) | Date of publication of the application | 2021.01.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2024.10.31 |
| (30) | Priority | 201862631383 P, 2018.02.15, US |
| (74) | Patent attorney | (Procedură) SOCOLOVA Sofia, Str. Drumul Viilor nr. 42, bloc 3, ap. 60, MD-2021, Chişinău, Republica Moldova |
| (86) | International application | PCT/IB2019/051214, 2019.02.14 |
| (87) | International publication | WO 2019/159110, 2019.08.22 |